As immunotherapy for cancer continues to evolve—so has the Association of Community Cancer Centers—adapting to meet the changing needs of the oncology community.
The ACCC Immuno-Oncology Institute is the only initiative dedicated to educating multidisciplinary teams to go beyond a clinical understanding of IO and tackle real-world implementation issues. With the care of patients on immunotherapies now extending beyond the cancer team, the ACCC Immuno-Oncology Institute is at the forefront of developing critical education to empower healthcare professionals across care delivery settings.
Under the guidance of the IO Institute Executive Committee, multispecialty Working Groups were established to focus on Big Data, Telemedicine, Care Coordination and Communication, and Training and Education. IO Working Groups members share their expertise, knowledge, and forward-looking perspectives to provide a framework for developing proactive strategies for effective delivery of these new and emerging therapies.
Best Practices for Implementing Cancer Immunotherapy in the Community
CAR-T Cell Therapies in Community Oncology
The Evolving Immunotherapeutic Landscape in Renal Cell Carcinoma
Managing Immune-Related Adverse Events
Optimizing Outcomes for Patients with Urothelial Carcinoma
Overcoming Obstacles in Integrating Immunotherapies for Cancer in the Community Setting
Preparing Community Providers for Bispecific Antibodies
Survivorship in the Era of IO
ACCC Releases Annual Report on Current State of Immuno-Oncology - via The ASCO Post
Community Oncology Professionals Highlight Need for More Education on Immunotherapies - via Targeted Oncology
ACCC Survey Reveals Biggest Challenges and Concerns Regarding IO Therapies - via AJMC
ACCC Report: Immunotherapy Research Grew in 2020 Despite COVID-19 Pandemic - via OncLive
ACCC Immuno-Oncology Institute Releases Report on the State of Immuno-Oncology
Where Does Survivorship Stand in the Era of Immuno-Oncology? - via Oncology Times
Improving Immunotherapy Implementation in Community Practice - via Oncology Nursing News
An Evidence-Based Argument Is Often the Fastest Route to Immunotherapy Authorization - via OncLive
Telemedicine working group aims to address ‘big gaps’ of emergency cancer care - via HemOnc Today
Download IO Wallet Card
Download Article & Companion Guide
See All Immuno-Oncology Insights